glp 1 hfpef GLP-1RA in Different Phenotypes Mechanisms of GLP-1 Receptor Agonists

Going forward, clinicians may consider integrating GLP-1 RAs into the treatment regimens for patients with RAO, not only to target obesity-related complications but also possibly to target the underlying inflammatory disease process

Hes smart

Protocol for monitoring fatty acid trafficking from lipid droplets to mitochondria in cultured cells

Stress development may obstruct the bodys detoxification process

AIFM1 mutations disrupt FAD binding, resulting in protein instability, mitochondrial dysfunction, and neurodegenerative phenotypes including brainstem atrophy and motor impairment

Frontiers in alopecia areata pathobiology research